SUMMARY Peripheral blood lymphocytes from patients with rheumatoid arthritis and osteoarthritis were examined for evidence of oligoclonal B cell expansion using the computer assisted flow cytometric technique of kappa-lambda (x-k) analysis. Eleven of 29 patients with rheumatoid arthritis but only one of 16 with osteoarthritis gave abnormal results (p<0O025). Abnormal x-k determinations did not correlate with age, duration of disease, presence of rheumatoid factor, or other clinical and laboratory parameters. Therapy with oral or intramuscular gold compounds appeared to diminish the incidence of x-k abnormality. These findings may indicate defective control of clonal B cell proliferation in rheumatoid arthritis.
cal B cell responses. Relatively scant information, however, is available concerning the phenotypic characterisation of B lymphocytes in patients with RA or the possible presence of abnormal numbers of B cells belonging to particular subsets or individual clones.
Recently, computer assisted flow cytometric methods have been developed that permit detection of subtle monoclonal or oligoclonal expansion of B cell clones in the peripheral blood lymphocyte population of patients with lymphoproliferative disorders, even when the lymphocyte populations are normal by conventional morphological criteria.26 Using such a technique, called 'x-k analysis', we asked whether evidence of oligoclonal B cell excess could be detected in RA.
Patients and methods

PATI ENTS
We studied 29 outpatients with definite or classical RA (mean age 53, range group 27 28 titres.
In the present study patients were not systematically characterised with respect to the presence or absence of Sjogren's syndrome. Sjogren's syndrome is characterised by polyclonal hypergammaglobulinaemia and can evolve into a monoclonal B cell neoplasm.29-32 Recent studies using high resolution electrophoretic techniques have identified monoclonal light chains in the serum and urine of a high proportion of patients with Sjogren's syndrome.33 34 x-k Analysis of B cells from patients with Sjogren's syndrome, both primary and secondary, and patients with other rheumatic diseases, such as systemic lupus erythematosus, will be of interest.
Several studies have suggested that patients with RA are subject to an increased risk of B cell neoplasms not related to exposure to immunosuppressive drugs.35*' The multiple immunoregulatory disturbances found in RA provide a possible explanation for this phenomenon.4' Although the abnormalities in x-k analysis found among our RA patients are more subtle than those seen in overt lymphoma, they are comparable to findings in patients with lymphoma in apparent remission who subsequently developed a clinical recurrence. 2 4 In patients with RA such abnormalities may indicate defective T cell control of clonal B cell expansion which, in a small number of individuals, could eventually result in overt B cell malignancy. At present, however, this hypothesis remains speculative, and larger longitudinal studies will be needed to address such issues definitively. 
